
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNUEZMd3FERkQ2YnFrUDllNEtTVW02blM1VW9zSnJQSVBjeFhsbVB0Y1lGbXRQUG5KZlhZZEN2aHNZU05ZYkR5YWtLeUdwb2MzTkZiWVdieHF5OTRodzBNQjVpMmVuSjZ2QzZ0NmdtekZpUzdicDZ5Q0JOUV9CSFhEZ01NUVlwdm56SGk4Skt3VzZzajU1V0E1cks4dmNYN0Z0aWZuZ2tJTXBhTE1TbTJmMTVmUTJxMl9tcEpIcWlES2laczFyOTAzX1Nn?oc=5" target="_blank">M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmaceutical Executive</font>
